| 12427193 |
Subcutaneous anti-HER2 antibody formulations and uses thereof |
Michael Adler, Ulla Grauschopf, Hanns-Christian Mahler |
2025-09-30 |
| 11767363 |
High concentration antibody-containing liquid formulation |
Toshiyuki MORICHIKA, Daisuke Kameoka, Yoshimi IMAEDA, Terutoshi MAEDA |
2023-09-26 |
| 11584798 |
High concentration antibody-containing liquid formulation |
Toshiyuki MORICHIKA, Daisuke Kameoka, Yoshimi IMAEDA, Terutoshi MAEDA |
2023-02-21 |
| 11359026 |
High concentration antibody-containing liquid formulation |
Toshiyuki MORICHIKA, Daisuke Kameoka, Yoshimi IMAEDA, Terutoshi MAEDA |
2022-06-14 |
| 11008394 |
High concentration antibody-containing liquid formulation |
Toshiyuki MORICHIKA, Daisuke Kameoka, Yoshimi IMAEDA, Terutoshi MAEDA |
2021-05-18 |
| 10752696 |
Highly concentrated pharmaceutical formulations |
Michael Adler, Hanns-Christian Mahler |
2020-08-25 |
| 10377831 |
Highly concentrated pharmaceutical formulations |
Michael Adler, Hanns-Christian Mahler |
2019-08-13 |
| 10280227 |
Highly concentrated pharmaceutical formulations |
Michael Adler, Hanns-Christian Mahler |
2019-05-07 |
| 9968676 |
Subcutaneous anti-HER2 antibody formulations and uses thereof |
Michael Adler, Ulla Grauschopf, Hanns-Christian Mahler |
2018-05-15 |
| 9345661 |
Subcutaneous anti-HER2 antibody formulations and uses thereof |
Michael Adler, Ulla Grauschopf, Hanns-Christian Mahler |
2016-05-24 |
| 8568720 |
High concentration antibody-containing liquid formulation |
Toshiyuki MORICHIKA, Daisuke Kameoka, Yoshimi IMAEDA, Terutoshi MAEDA |
2013-10-29 |
